Oncoceutics, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Philadelphia PA United States (2009)
Status: Acquired by Chimerix (2021)

Organization Overview

First Clinical Trial
2014
NCT02038699
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Oncoceutics, Inc.